glp 1 lipoprotein a GLP-1 receptor agonists associated with better cardiovascular outcomes in obese or diabetic patients with elevated Lp(a) levels: Multicenter retrospective study High Lp(a)_Expert Insights & Future
Description
Diabetic kidney disease
This can happen even if you have never had heart failure or heart problems before
Thanks Tim K
GLP-1 agonists like semaglutide produce 15 to 22 percent body weight reduction in clinical trials
Current evidence does not establish a causal link between GLP-1 medicines and increased overall cancer risk in humans
Denominator (All Adults) The number of adult patients who have either a recorded body mass index (BMI) or a prescription, medication dispense, or patient recorded medication in the quarter
